Home » Topics » BioWorld Science

BioWorld Science
RSS

Common pathway may underlie schizophrenia and PD

Aug. 21, 2018

Harbour BioMed licenses ex-China rights to Kelun-Biotech's A-167

Aug. 21, 2018

Polymorphisms in miRNA-146a and IRAK1 are associated with susceptibility to SLE and MS

Aug. 21, 2018

Adipose-derived regenerative cell therapy safe in patients with erectile dysfunction

Aug. 21, 2018

Celleron enrolls first patient in phase Ib/II study of CXD-101 with nivolumab for colorectal cancer

Aug. 20, 2018

European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss

Aug. 20, 2018

FDA approves Eylea injection sBLA in wet AMD

Aug. 20, 2018

Let there be no light damage

Aug. 20, 2018

Vaccinations initiated in first-in-human trial of novel attenuated Zika vaccine

Aug. 20, 2018

Immunocore initiates phase I study of IMCnyeso under GSK collaboration

Aug. 20, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026